---
title: "HOBERMAN KENNETH — Ownership Dossier"
canonical: https://whiteintel.dev/entity/50af4649-8775-5bbf-97b6-4efdf35688bb
json: https://whiteintel.dev/api/public/dossier/50af4649-8775-5bbf-97b6-4efdf35688bb
identifier: sec:0001573722
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# HOBERMAN KENNETH

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001573722`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/50af4649-8775-5bbf-97b6-4efdf35688bb  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/50af4649-8775-5bbf-97b6-4efdf35688bb  

## Ownership & control

### Holdings / subsidiaries

- **Nuvectis Pharma, Inc.** (director) — https://whiteintel.dev/entity/b22d2d51-d8ce-5b5b-bbf2-dea9efa548cb
- **TG THERAPEUTICS, INC.** (director) — https://whiteintel.dev/entity/9c13e806-71d9-5ea4-8db4-d751fc718108
- **STEMLINE THERAPEUTICS INC** (officer) — https://whiteintel.dev/entity/54176adc-6963-5856-87d1-2e3b7d77b692

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **HOBERMAN KENNETH**. Human view: https://whiteintel.dev/entity/50af4649-8775-5bbf-97b6-4efdf35688bb · Structured JSON: https://whiteintel.dev/api/public/dossier/50af4649-8775-5bbf-97b6-4efdf35688bb._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._